Search
for

    Sort by

    Research 121–150 of 1000+

    1. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases Current Medicinal Chemistry · 2016 · 11 citations
    2. Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride Journal of Medicinal Food · 2011 · 8 citations
    3. Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis 2019 · 4 citations
    4. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders. PubMed · 2013 · 3 citations
    5. 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향 Journal of the Korean Society of Food Science and Nutrition · 2014 · 1 citations
    6. High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma Journal of Chromatography B: Biomedical Sciences and Applications · 1997 · 1 citations
    7. African Journal of Biomedical Research 2025
    8. Structural basis for the catalysis and inhibition of human steroid 5α‐reductase 2 The FASEB Journal · 2021
    9. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    10. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    11. Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases The Journal of Steroid Biochemistry and Molecular Biology · 2013 · 51 citations
    12. The search for bioactive compounds in tropical plants to target hormone imbalance associated diseases edoc (University of Basel) · 2007 · 2 citations
    13. 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione Acta Crystallographica Section C-crystal Structure Communications · 1998
    14. Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors Current Enzyme Inhibition · 2022
    15. Structure of human type II 5 alpha-reductase gene. Endocrinology · 1992 · 124 citations
    16. Pre-receptor regulation of the androgen receptor Molecular and cellular endocrinology · 2007 · 56 citations
    17. Significance of the polyglutamine tract polymorphism in the androgen receptor Urology · 2001 · 54 citations
    18. Selective non-steroidal inhibitors of 5α-reductase type 1 2004 · 49 citations
    19. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    20. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    21. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    22. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    23. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    24. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    25. Finasteride for prostatic disease: an updated and comprehensive review Expert opinion on drug metabolism & toxicology · 2008 · 14 citations
    26. New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide) Steroids · 2005 · 14 citations
    27. Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura Actas Urológicas Españolas · 2003 · 14 citations
    28. Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist Tetrahedron Letters · 1994 · 14 citations
    29. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    30. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations